Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The FAP-FDG Integration Score (FFIS): Development and prognostic validation of a dual-tracer PET phenotype for solid tumors.

European journal of nuclear medicine and molecular imaging - 1 Jul 2026

Liu Ya, Zhang Ting, Deng Jingwei, Yu Chang, Xu Tingting, Mou Lixian, Ding Haoyuan, Chen Yue

Abstract excerpt

PURPOSE: To develop a FAP-FDG integrated score (FFIS) based on [68Ga]Ga-FAP-2286 and [18F]F-FDG PET/CT, and evaluate its prognostic value for risk stratification compared to conventional single-parameter imaging. METHODS: This retrospective study included 193 patients with solid tumors who underwent both [18F]F-FDG and [68Ga]Ga-FAP-2286 PET/CT scans. Overall survival (OS) was the primary endpoint. The FFIS score...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Fluorodeoxyglucose F18

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to FAP gene

Share to Neoplasms

Share to Phenotype

Share to Positron Emission Tomography Computed Tomography

Share to Prognosis

Share to Radiopharmaceuticals

Source

Identifiers

PMID: 42191945
DOI: 10.1007/s00259-026-07951-x

Genes

FAP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The FAP-FDG Integration Score (FFIS): Development and prognostic validation of a dual-tracer PET phenotype for solid tumors.PMID 42191945Read ↗

Incorporating radiomic feature of pretreatment 18F-FDG PET improves survival stratification in patients with EGFR-mutated lung adenocarcinoma.Semantic proximity Read ↗

PET/CT imaging: The incremental value of assessing the glucose metabolic phenotype and the structure of cancers in a single examination.Semantic proximity Read ↗

Prognostic value of combining clinical factors, 18F-FDG PET-based intensity, volumetric features, and deep learning predictor in patients with EGFR-mutated lung adenocarcinoma undergoing targeted therapies: a cross-scanner and temporal validation study.Semantic proximity Read ↗

A Novel Prognostic Scoring System Based on F-18 FDG PET/CT Volumetric Parameters, Sarcopenia, and Clinical Variables in Patients Receiving Immunotherapy for Advanced Solid Tumors: The Immunotherapy Prognostic Score (IPS)Semantic proximity Read ↗

Prognostic significance of integrating total metabolic tumor volume and EGFR mutation status in patients with lung adenocarcinoma.Semantic proximity Read ↗

A Nomogram for the Prediction of Invasiveness in Invasive Pulmonary Adenocarcinoma on the Basis of Multimodal PET/CT Parameters.Semantic proximity Read ↗

[18F]FDG PET radiomics score generated by cross-combination approach for treatment response and prognosis prediction in primary gastrointestinal diffuse large B-cell lymphoma patientsSemantic proximity Read ↗

PET Imaging of Metabolism, Perfusion, and HypoxiaSemantic proximity Read ↗

A Two-way Comparison of Whole-body 18F-FDG PET/CT and PET/MRI for Distant Metastasis in Patients with Malignant Tumors: A Meta-analysisSemantic proximity Read ↗

Prognostic Value of Baseline 18F-FDG PET/CT Functional Parameters in Patients with Advanced Lung Adenocarcinoma Stratified by EGFR Mutation Status.Semantic proximity Read ↗

Metastasis risk prediction model in osteosarcoma using metabolic imaging phenotypes: A multivariable radiomics model.Semantic proximity Read ↗

Prognostic value of tumor metabolic imaging phenotype by FDG PET radiomics in HNSCC.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.